SCHEMBL5590185

SCHEMBL5590185

CCc1c(C)c(C)c(O)c(O)c1C(=O)O

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LDHA P00338 8/20 0.44
LDHB P07195 8/20 0.44
FASN P49327 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2C19 P33261 1/20 0.34
HSD17B10 Q99714 1/20 0.34
ALDH1A1 P00352 1/20 0.33
HCAR2 Q8TDS4 1/20 0.32
APP P05067 1/20 0.32
BACE1 P56817 1/20 0.32
LMNA P02545 1/20 0.32
PLA2G2A P14555 1/20 0.32
PLA2G5 P39877 1/20 0.32
CYP3A4 P08684 2/20 0.31
ACHE P22303 1/20 0.31
GLRA3 O75311 1/20 0.31
GLRB P48167 1/20 0.31
ALB P02768 2/20 0.31
MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5588178 0.84 LDHA (0.54) LDHALDHBFASNPLA2G2APLA2G5
SCHEMBL28928804 0.83 FASN (0.38) LDHALDHBFASNCYP1A2CYP2C19
SCHEMBL5586642 0.82 LDHA (0.45) LDHALDHBFASNHCAR2PLA2G2A
SCHEMBL31643874 0.81 FASN (0.39) LDHALDHBFASNCYP1A2CYP2C19
SCHEMBL28677095 0.81 FASN (0.39) LDHALDHBFASNCYP1A2CYP2C19
SCHEMBL13343473 0.80 ALDH1A1 (0.36) LDHALDHBCYP1A2CYP2C19HSD17B10
SCHEMBL668597 0.80 HSD17B10 (0.41) LDHALDHBFASNHSD17B10ALDH1A1
SCHEMBL5589707 0.79 LDHA (0.45) LDHALDHBFASNCYP1A2CYP2C19
SCHEMBL5586816 0.78 LDHA (0.43) LDHALDHBHSD17B10ALDH1A1HCAR2
SCHEMBL28939249 0.78 ALDH1A1 (0.37) LDHALDHBFASNCYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7247687-B2 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-07-24 US disclosed
EP-1521758-B1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEM PATENTS INC (US) 2006-05-24 EP disclosed
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. 2006-03-02 US disclosed
EP-1521758-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION Exxonmobil Chemical Patents Inc. (US) 2005-04-13 EP disclosed
WO-2004007509-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-01-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization MLX, LOX, LMTK3 LDHA 320/4885LDHB 486/4885FASN 1294/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.